MM-cell-induced MDSCs (CD11b+CD14-HLA-DR-CD33+CD15+CD38+ cells) were strongly reduced after Dara treatment, suggesting their sensitivity to Dara-mediated ADCC and CDC [49]. The gene discussed is CD38; the disease is Miyoshi myopathy.